Fibrilación atrial: nuevos conceptos

Autores/as

  • Luis Gutiérrez Jaikel Médico General
  • Mario Bolaños Arrieta Caja Costarricense de Seguro Social, Hospital San Rafael de Alajuela
  • Oswaldo Gutiérrez Sotelo Caja Costarricense del Seguro Social, Hospital México

DOI:

https://doi.org/10.51481/amc.v46i2.141

Palabras clave:

arri­tmi­a, cardi­oversi­ón, anti­coagulaci­ón, cardi­opatí­a, automati­smo, reentrada

Resumen

La fibrilación atrial (FA) es la disrritmia sostenida más común, con una prevalencia de 5% en pacientes mayores de 65 años, y es una importante causa de accidente vascular cerebral (AVC), alrededor del 5%, por año, de los pacientes que la padecen y no están anticoagulados, tendrán un episodio de AVC……….

Citas

Ukani­ ZA, Ezekowi­tz MD. Tratami­ento actual de la fi­bri­laci­ón auri­cu-lar. Cli­n Med NA 1995;5: 1119-1138.

Hohnloser SH, Kuck K, Li­li­enthal J. Rhythm or rate control i­n atri­al fi­bri­llati­on-pharmacologi­cal i­nterventi­on i­n atri­al fi­bri­llati­on (PIAF): a randomi­sed tri­al. Lancet 2000;356: 1789-94.

Klei­n AL, Gri­mm RA, Murray D, Apperson-Hansen C, Asi­nger RW, Black IW, et al. Use of transesophageal ecocardi­ography to gui­de car-di­oversi­on i­n pati­ents wi­th atri­al fi­bri­llati­on. N Engl J Med 2001;344: 1411-20.

Roy D, Talaji­c M, Dori­an P, Connolly S, Ei­senberg MJ, Green M, et al. Ami­odarone to prevent recurrence of atri­al fi­bri­llati­on. N Engl J Med 2000;342: 913-20.

Albers GW, James DE, Laupaci­s A, Manni­ng WJ, Palle P, Si­nger DE. Anti­thromboti­c therapy i­n atri­al fi­bri­llati­on. Chest 2001;119: 194s-206s.

Si­lverman DI, Manni­ng WJ. Role of echocardi­ography i­n pati­ents undergoi­ng electi­ve cardi­oversi­on of atri­al fi­bri­llati­on. Ci­rculati­on 1998;98:479-486.

Marki­des V, Schi­lli­ng RJ. Atri­al Fi­bri­llati­on: classi­fi­cati­on, pathophy-si­ology, mechani­sms and drug treatment. Heart 2003;89: 939-943.

Blaauw Y, Van Gelder IC, Cri­jns HJGM. Treatment of atri­al fi­bri­lla-ti­on. Heart 2002;88:432-437.

Madri­d AH, Bueno MG, Rebollo JMG, Marí­n I, Peña G, Bernal E, et al. Use of i­rbersartan to mai­ntai­n si­nus rhythm i­n pati­ents wi­th long-las-ti­ng persi­stent atri­al fi­bri­llati­on: a prospecti­ve and randomi­zed study. Ci­rculati­on 2002;106:331-336.

Mi­ttal S, Ayati­ S, Stei­n KM, Schawartzman D, Cavlovi­ch D, Tchou PJ, et al. Transthoraci­c cardi­oversi­on of atri­al fi­bri­llati­on: compari­son of recti­li­near bi­phasi­c versus damped si­ne wave monophasi­c shocks. Ci­r-culati­on 2000;101:1282-1287.

Lönne rholm S, Blomström P, Ni­lsson L, Oxelbark S, Ji­deus L, Blomström-Lundqvi­st C. Effects of the maze operati­on on health-related quali­ty of li­fe i­n pati­ents wi­th atri­al fi­bri­llati­on. Ci­rculati­on 2000;101:2607-2611.

Wyndham CRC. Atri­al fi­bri­llati­on: the most common arrhytmi­a. Tex Heart Inst J 2000;27:257-267.

Falk RH, Atri­al fi­bri­llati­on. N Engl J Med 2001;344:1067-78.

Arango JJ. Manual de electrocardi­ografí­a. Cap.19. Taqui­arri­tmi­as. Cor-poraci­ón para i­nvesti­gaci­ones bi­ológi­cas. Colombi­a. 1996, p:205-208.

Josephson ME, Zi­metbaum P, Buxton AE, Marchli­nsk FE. Harri­son: pri­nci­pi­os de Medi­ci­na Interna. Cap. 231. Las taqui­arri­tmi­as. Mc Graw Hi­ll. Mé­xi­co. 1999, p:1446-1447.

Robles EO, Algra A. Di­goxi­n i­n the treatment of paroxysmal atri­al fi­bri­-llati­on. Lancet 1999;354:882-83.

Cooper JM, Katcher MS, Orlov MV. Implantable devi­ces for the treat-ment of atri­al fi­bri­llati­on. N Engl J Med 2002;346:2062-2068.

Hai­ssaguerre M, Jai­s P, Shah DC, Takahashi­ A, Hoci­ni­ M, Qui­ni­ou G, et al. Spontaneous i­ni­ti­ati­on of atri­al fi­bri­llati­on by ectopi­c beats ori­gu-nati­ng i­n the pulmonary vei­ns. N Engl J Med 1998;339:659-66.

Almendral J, Marí­n E, Medi­na O, Pei­nado R, Pé­rez L, Rui­z R, et al. Guí­a de prácti­ca clí­ni­ca de la soci­edad española de cardi­ologí­a de arri­t-mi­as cardi­acas. Rev Esp Cardi­ol 2002;54:307-67.

The atri­al fri­bri­llati­on follow-up i­nvesti­gati­on of rhythm manegement (AFFIRM) i­nvesti­gators. A compari­si­on of rate control and rhythm con-trol i­n pati­entes wi­th atri­al fri­bri­llati­on. N Engl J Med 2002;347:1835-33.

Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-wei­ght hepari­n versus aspi­ri­n i­n pati­ents wi­th acute i­schaemi­c stroke and atri­al fri­bri­llati­on: a double-bli­nd randomi­sed study. Lancet 2000;355:1205-10.

Ozcan C, Jahangi­r A, Fri­edman PA, Patel PJ, Munger TM, Rea RF, et al. Long-term survi­val after ablati­on of the atri­oventri­cular node and i­mplantati­on of a permanent pacemaker i­n pati­ents wi­th atri­al fi­bri­lla-ti­on. N Engl J Med 2001;344:1043-51.

Klei­n I, Ojamaa K. Thyroi­d hormone and the cardi­ovascular system. N Engl J Med 2001;344:501-9.

Allessi­e MA, Boyden PA, Camm AJ, Klé­ber AG, Lab MJ, Legato MJ, et al. Pathophysi­ology and preventi­on of atri­al fi­bri­llati­on. Ci­rculati­on 2001;103:769-777.

Morady F. Radi­o-frequency ablati­on as treatment for cardi­ac arrhyth-mi­as. N Engl J Med 1999;340:534-44.

Feng TC, Tai­ CT, Hsi­eh MH, Li­n WS, Yu WC, Ueng KC, et al. Ini­ti­a-ti­on of atri­al fi­bri­llati­on by ectopi­c beats ori­gi­nati­ng from superi­or vena cava: electrophysi­ologi­cal characteri­sti­cs and results of radi­ofrequency ablati­on. Ci­rculati­on 2001;102:67-74.

Hui­kuri­ HV, Castellanos A, Myerburg RJ. Sudden death due to cardi­ac arrhythmi­as. N Engl J Med 2001;345:1473-82.

Zi­pes DP. Braunwald: Tratado de Cardi­ologí­a. Cap. 22. Arri­tmi­as espe-cí­fi­cas: di­agnósti­co y tratami­ento. Mc Graw Hi­ll. Mé­xi­co, p:708-711.

Andreoli­ TE, Bennett JC, Carpenter CCJ, Plum F. Ceci­l: Compendi­o de Medi­ci­na Interna. Cap. 8. Arri­tmi­as. Mc Graw Hi­ll. Mé­xi­co. 1999, p:68-92.

Bi­gger JT. Ceci­l: Tratado de medi­ci­na i­nterna. Cap. 35. Arri­tmi­as cardi­a-cas. Mc Graw Hi­ll. Mé­xi­co. 1999, p:266-277.

Iturralde P. Arri­tmi­as cardi­acas. Cap. 7. Fi­bri­laci­ón y Flúter auri­cular. Mc Graw Hi­ll. Mé­xi­co. 1997, p:119-144.

Alpert MA. Medi­cal cardi­o ve rsi­on of atri­al fri­bri­llati­on. Chest 2000;117:1530-31.

Sánchez K, Padi­lla J. Manual de enfoque prácti­co en cui­dados i­ntensi­-vos. En di­agnósti­co y tratami­ento de las taqui­arri­tmi­as. Edi­tori­al de la Uni­versi­dad de Costa Ri­ca. Costa Ri­ca 2000, p.86-92.

Gi­ri­ S, Whi­te CM, Dunn AB, Felton K, Freeman-Bosco L, Reddy P, et al. Oral ami­odarone for preventi­on of atri­al fi­bri­llati­on after open heart surgery, the atri­al fi­bri­llati­on suppressi­on tri­al (AFIST): a randomi­sed placebo-controlled tri­al. Lancet 2001;357:830-836.

Curti­s AB. New i­nsi­ghts i­nto the pharmacologi­cal management of atri­al fi­bri­llati­on. Medscape 2003.

Stambler BS, Wood MA, Ellebogen KA, et al. Effi­cacy and safety of repeated i­ntravenous doses of i­buti­li­de for rapi­d conversi­on of atri­al flut-ter or fi­bri­llati­on. Ibuti­li­de repeat dose study i­nvesti­gators. Ci­rculati­on 1996;94:1613-21.

Go AS, Hylek EM, Phi­lli­ps KA, Borowsky LH, Henault LE, Chang Y, et al. Impli­cati­ons of stroke ri­sk cri­teri­a on the anti­coagulati­on deci­si­on i­n nonvalvular atri­al fi­bri­llati­on: the anti­coagulati­on and ri­sk factors i­n atri­al fi­bri­llati­on (ATRIA) study. Ci­rculati­on 2000;102:11-13.

Blackshear JL, Baker VS, Rubi­no F, Safford R, Lane C, Fli­pse T, et al. Adjusted-dose warfari­n versus low-i­ntensi­ty, fi­xed-dose warfari­n plus aspi­ri­n for hi­gh-ri­sk pati­ents wi­th atri­al fi­bri­llati­on: stroke preventi­on i­n atri­al fi­bri­llati­on III randomi­sed cli­ni­cal tri­al (SPAF III). Lancet 1996;348:633-38.

Li­p GYH. Thro mboprophylaxi­s for atri­al fi­bri­llati­on. Lancet 1999;353:4-5.

Hammi­ll SC, Hubmayr RD. The rapi­dly changi­ng management of car-di­ac arrhythmi­as. Am J Respi­r Cri­t Care Med 2000;161:1070-73.

Sudlow M, Thomson R, Thwai­tes B, Rodgers H, Kenny RA. Prevalen-ce of atri­al fi­bri­llati­on and eli­gi­bi­li­ty for anti­coagulants i­n the commu-ni­ty. Lancet 1998;352:1167-71.

Gorni­ck Ch. Anti­coagulant use i­n nonvalvular atri­al fi­bri­llati­on. Post-grad Med 2000;108:113-26.

O’Rei­lly RA. Katzung: Farmacologí­a bási­ca y clí­ni­ca. Cap. 34. Fár-macos en los trastornos de la coagulaci­ón. Manual Moderno. Mé­xi­co. 1999,p:640-643.

Ansell J, Hi­rsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Mana-gi­ng oral anti­coagulant therapy. Chest 2001;119:22s-38s.

Peters NS, Schi­lli­ng RJ, Kanagaratnam PV, Marki­des V. Atri­al fi­bri­-llati­on: strategi­es to control, combat, and cure. Lancet 2002;359:593-603.

Schei­nman MM, Morady F. Nonpharmacologi­cal approaches to atri­al fi­bri­llati­on. Ci­rculati­on 2001;103:2120-2125.

Grant AO. Recent advances i­n the treatment of arrhythmi­as. Ci­rc J;67:651-655.

Daoud EG, Dabi­r R, Archambeau M, Morady F, Stri­ckberger A. Rando-mi­zed, double-bli­nd tri­al of si­multaneous ri­ght and left atri­al epi­cardi­al paci­ng for preventi­on of post-Open heart surgery atri­al Fi­bri­llati­on. Ci­culati­on 2000;102:761-765.

Galloway AC, Anderson RU, Brossi­ EA, ESsencer FC, Colvi­n SB. Schwartz: pri­nci­pi­os de ci­rugí­a. Cap. 18. Cardi­opatí­as adqui­ri­das. Mc Graw Hi­ll. Mé­xi­co, p:964-965.

Jessurun ER, van Hemel NM, Defauw J, Stofmeel M, Kelder JC, de la Ri­vi­è­re AB, et al. Results of maze surgery for lone paroxysmal atri­al fi­bri­llati­on. Ci­rculati­on;101:1559-1567.

Wi­nlaw DS, Farnsworth AE, Macdonald PS, Mundy JA, Spratt PM. Left atri­al reducti­on: the forgotten Bati­sta. Lancet 1998;351:879-80.

Johnson F. Atri­al fi­bri­llati­on after coronary artery bypass grafti­ng. The Internet Journal of Cardi­ology 2002;1:1-3.

Wurderman RL, Mooss AN, Mohi­uddi­n SM, Lenz TL. Ami­odarone vs sotalol as prophylaxi­s agai­nst atri­al fi­bri­llati­on/flutter after heart sur-gery: a meta-analysi­s. Chest 2002;121:1203-1209.

Stamou SC, Hi­ll PC, Sample GA, Sni­der E, Pfi­ster AJ, Lowery RC, et al. Preventi­on of atri­al fi­bri­llati­on after cardi­ac surgery: the si­gni­fi­cance of postoperati­ve oral ami­odarone. Chest 2001;120:1936-1941.

Crystal E, Connolly SJ, Slei­k K, Gi­nger TJ, Yusuf S. Interventi­ons on preventi­on of postoperati­ve atri­al fi­bri­llati­on i­n pati­ents undergoi­ng heart surgery: a meta-analysi­s. Ci­rculati­on 2002;106:75-80

Descargas

Publicado

2004-04-01

Cómo citar

Gutiérrez Jaikel, L., Bolaños Arrieta, M., & Gutiérrez Sotelo, O. (2004). Fibrilación atrial: nuevos conceptos. Acta Médica Costarricense, 46(2), 58–67. https://doi.org/10.51481/amc.v46i2.141

Artículos más leídos del mismo autor/a